• Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Peer Review Process
  • Guide for Authors
  • Submit Manuscript
  • Reviewers
  • Contact Us
 
  • Login
  • Register
Home Articles List Article Information
  • Save Records
  • |
  • Printable Version
  • |
  • Recommend
  • |
  • How to cite Export to
    RIS EndNote BibTeX APA MLA Harvard Vancouver
  • |
  • Share Share
    CiteULike Mendeley Facebook Google LinkedIn Twitter
International Journal of Cancer and Biomedical Research
arrow Articles in Press
arrow Current Issue
Journal Archive
Volume Volume 4 (2020)
Issue Issue 3
Issue Issue 2
Issue Special Issue
Issue Issue 1
Volume Volume 3 (2019)
Volume Volume 2 (2018)
Volume Volume 1 (2017)
Bedeer, A., El-Rashidy, M., Elzayat, S., Elsherif, H. (2020). Evaluation of the prognostic significance of P53 and Proliferating cell nuclear antigen (PCNA) in laryngeal squamous cell carcinoma. International Journal of Cancer and Biomedical Research, 4(3), 169-176. doi: 10.21608/jcbr.2020.31528.1042
Asmaa Bedeer; Mohamed El-Rashidy; Saad Elzayat; Hossam Elsherif. "Evaluation of the prognostic significance of P53 and Proliferating cell nuclear antigen (PCNA) in laryngeal squamous cell carcinoma". International Journal of Cancer and Biomedical Research, 4, 3, 2020, 169-176. doi: 10.21608/jcbr.2020.31528.1042
Bedeer, A., El-Rashidy, M., Elzayat, S., Elsherif, H. (2020). 'Evaluation of the prognostic significance of P53 and Proliferating cell nuclear antigen (PCNA) in laryngeal squamous cell carcinoma', International Journal of Cancer and Biomedical Research, 4(3), pp. 169-176. doi: 10.21608/jcbr.2020.31528.1042
Bedeer, A., El-Rashidy, M., Elzayat, S., Elsherif, H. Evaluation of the prognostic significance of P53 and Proliferating cell nuclear antigen (PCNA) in laryngeal squamous cell carcinoma. International Journal of Cancer and Biomedical Research, 2020; 4(3): 169-176. doi: 10.21608/jcbr.2020.31528.1042

Evaluation of the prognostic significance of P53 and Proliferating cell nuclear antigen (PCNA) in laryngeal squamous cell carcinoma

Article 3, Volume 4, Issue 3, Autumn 2020, Page 169-176  XML PDF (2.53 MB)
Document Type: Original Article
DOI: 10.21608/jcbr.2020.31528.1042
Authors
Asmaa Bedeer email 1; Mohamed El-Rashidy1; Saad Elzayat2; Hossam Elsherif3
1Pathology Department, Faculty of Medicine, Tanta university, Tanta, Egypt.
2ENT Department, Faculty of Medicine, Kafr Elsheikh University, Egypt.
3ENT Department, Faculty of Medicine, Tanta university, Tanta, Egypt.
Abstract
Background: Laryngeal tumors are considered to be the most frequent neoplasm of head and neck cancers, they account for almost 25% of the malignant neoplasms involving this region. Even though it shows better clinical outcome, its prognosis still worse due to its local invasiveness, lymph node and distant metastasis. Thus, a better realization of the molecular pathways developing laryngeal carcinogenesis may help in the identification of new predictive and prognostic biomarkers, and developing novel management strategies for this cancer. Material and methods: This study included 40 cases of laryngeal squamous cell carcinoma (LSCC), 38 cases were received as punch biopsies and only 2 cases were received as excisional biopsies. Immunohistochemical staining of all cases using P53 and PCNA was done. Results: The immunohistochemical expression of p53 was positive in the nuclei of 31 out of 40 (77.5%) LSCC cases. PCNA expression was positive in 28 out of 40 (70%) LSCC cases. P53 expression was significantly correlated with the increase in tumor size, higher tumor stageand lymph node invasion.PCNA expression, as well, was significantly correlated with the increase in tumor size, higher tumor stage, tumor grade, tumor site and lymph node invasion.Conclusions: p53 and PCNA are properly independent predictors of the outcomes in patients with LSCC, and their immunohistochemical expression may aid in predicting the clinical course in patients with LSCC, and selecting patients who should be treated more cautiously.
Keywords
laryngeal carcinoma LSCC; p53; PCNA
Main Subjects
Inflammatory and cancer
Statistics
Article View: 219
PDF Download: 55
Home | Glossary | News | Aims and Scope | Sitemap
Top Top

Journal Management System. Designed by NotionWave.